PHARMAZZ, INC.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2010-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.pharmazz.com
Clinical Trials
13
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients
- First Posted Date
- 2023-07-21
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Pharmazz, Inc.
- Target Recruit Count
- 400
- Registration Number
- NCT05956418
- Locations
- 🇮🇳
ACSR Government Medical College and Hospital, Nellore, Andhra Pradesh, India
🇮🇳All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh, India
🇮🇳Aman Hospital, Vadodara, Gujarat, India
Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- Conditions
- Acute Cerebral Ischemia
- Interventions
- Other: Normal Saline
- First Posted Date
- 2023-07-21
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Pharmazz, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT05955326
- Locations
- 🇮🇳
Guntur Medical College and Government General Hospital, Guntur, Andhra Pradesh, India
🇮🇳Lalitha Super Specialities Hospital Pvt. Ltd., Guntur, Andhra Pradesh, India
🇮🇳Radiant Superspeciality Hospital, Amaravati, Maharashtra, India
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- First Posted Date
- 2023-01-19
- Last Posted Date
- 2025-09-05
- Lead Sponsor
- Pharmazz, Inc.
- Target Recruit Count
- 514
- Registration Number
- NCT05691244
- Locations
- 🇺🇸
The University of Arizona - College of Medicine, Tuscon, Arizona, United States
🇺🇸St. John's Regional Medical Center, Oxnard, California, United States
🇺🇸Intercoastal Medical Group, Sarasota, Florida, United States
Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
- Conditions
- Hypoxic-Ischemic EncephalopathyNeonatal AsphyxiaNeonatal Encephalopathy
- Interventions
- Drug: Normal Saline along with standard treatmentDrug: Sovateltide along with standard treatment
- First Posted Date
- 2022-08-24
- Last Posted Date
- 2025-05-12
- Lead Sponsor
- Pharmazz, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05514340
- Locations
- 🇮🇳
Father Muller Medical College Hospital, Mangalore, Karnataka, India
🇮🇳Christian Medical College and Hospital, Ludhiana, Punjab, India
🇮🇳Niloufer Hospital, Hyderabad, Telangana, India
A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent
- Conditions
- Hypovolemic Shock
- Interventions
- Drug: Normal Saline
- First Posted Date
- 2022-02-22
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- Pharmazz, Inc.
- Target Recruit Count
- 430
- Registration Number
- NCT05251181
- Prev
- 1
- 2
- 3
- Next